In this free webinar, learn how expert-led pathology supports translational research and clinical trials at every stage. Attendees will gain insight into how expert pathology leadership supports trial design and execution. The featured speaker will discuss the role of digital pathology in enabling faster turnarounds and global collaboration. Attendees will also understand why pathology should […]

Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics' Global Phase 3 Trials of Dotinurad for the Treatment of Gout GlobeNewswire October 21, 2025 MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Urica Therapeutics, Inc. (“Urica” or the “Company”), a Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) subsidiary, today announced that Crystalys Therapeutics,

Today marks the official launch of Oakledge Advisors, a new independent advisory firm founded to help institutional investors, asset managers, and ecosystem partners navigate the challenges and opportunities of aligning long-term capital with the evolving economy and disrupted climate system. Drawing on more than 15 years of experience in sustainable finance and policy – including

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced it will release its third quarter 2025 financial and operating results on Monday, November 3, 2025, following the close of trading. Halozyme will host a conference call on Monday, November 3, 2025 at 1:30 p.m. PT/4:30 p.m. ET to discuss the results. The conference call may be

Prospectively designed for scalability and re-dosability, Immusoft's engineered B cells represent the next generation of advanced therapeutics Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ISP-001, the Company's lead investigational therapy for the treatment of

Quad/Graphics, Inc. (NYSE: QUAD) (“Quad” or the “Company”), a marketing experience company that solves complex marketing challenges for its clients, today announced that its Board of Directors declared a quarterly dividend on the Company's common stock of $0.075 per share. https://mma.prnewswire.com/media/2429040/Quad_Wordmark_Logo.jpg The dividend is payable on December 5, 2025, to shareholders of record as of

CHICAGO, ILLINOIS / ACCESS Newswire / October 21, 2025 / (NYSE:KFS) Kingsway Financial Services Inc. ("Kingsway" or the "Company"), the only publicly-traded US company employing the Search Fund model to acquire and build great businesses, today announced that Colter Hanson has joined as the Company’s newest Operator-in-Residence within the Kingsway Search Xcelerator Segment ("KSX"). "I

(NASDAQ:GMM), BEIJING, Oct. 21, 2025 (GLOBE NEWSWIRE) — Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual content production and the development of 3D digital assets for use in the broader digital content industry, today announced that its Chief Marketing Officer (CMO), Nan Zhang,

(PinkSheets:ECGI),(Pinksheets:ECGI), IRVINE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — via IBN — ECGI Holdings, Inc. (OTC: ECGI) today announced that it has secured an institutional financing facility of up to $25 million. The facility strengthens ECGI's financial position by providing access to institutional growth capital to support expansion initiatives and advance larger acquisitions currently under

(NASDAQ:AREB),(NASDAQ:AREBW), Provo, UT, Oct. 21, 2025 (GLOBE NEWSWIRE) — Champion Safe Company (championsafe.com), a premier manufacturer of high-security safes and a proud subsidiary of American Rebel Holdings, Inc. (NASDAQ: AREB), America's Patriotic Brand, is proud to spotlight Cross Creek Outdoor Supplies in Henderson, North Carolina, for its exceptional performance in the Southeast region. In a